These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 38763711)
1. Carboxymethyl cellulose-based rotigotine nanocrystals-loaded hydrogel for increased transdermal delivery with alleviated skin irritation. Park JS; Seo JH; Jeong MY; Yang IG; Kim JS; Kim JH; Ho MJ; Jin SG; Choi MK; Choi YS; Kang MJ Carbohydr Polym; 2024 Aug; 338():122197. PubMed ID: 38763711 [TBL] [Abstract][Full Text] [Related]
2. Dissolving microarray patches loaded with a rotigotine nanosuspension: A potential alternative to Neupro® patch. Li Y; Wang J; Vora LK; Sabri AHB; McGuckin MB; Paredes AJ; Donnelly RF J Control Release; 2024 Aug; 372():304-317. PubMed ID: 38906420 [TBL] [Abstract][Full Text] [Related]
3. Lower irritation microemulsion-based rotigotine gel: formulation optimization and in vitro and in vivo studies. Wang Z; Mu HJ; Zhang XM; Ma PK; Lian SN; Zhang FP; Chu SY; Zhang WW; Wang AP; Wang WY; Sun KX Int J Nanomedicine; 2015; 10():633-44. PubMed ID: 25609965 [TBL] [Abstract][Full Text] [Related]
4. Development of novel pH-sensitive nanoparticles loaded hydrogel for transdermal drug delivery. Qindeel M; Ahmed N; Sabir F; Khan S; Ur-Rehman A Drug Dev Ind Pharm; 2019 Apr; 45(4):629-641. PubMed ID: 30633578 [TBL] [Abstract][Full Text] [Related]
5. Effect of Dispersion Medium on Pharmacokinetic Profile of Rotigotine Crystalline Suspension following Subcutaneous Injection. Kim MS; Ho MJ; Joung MY; Choi YS; Kang MJ Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559123 [TBL] [Abstract][Full Text] [Related]
6. Investigation on the effect of deep eutectic formation on drug-polymer miscibility and skin permeability of rotigotine drug-in-adhesive patch. Liu C; Qu X; Song L; Shang R; Wan X; Fang L Int J Pharm; 2020 Jan; 574():118852. PubMed ID: 31759103 [TBL] [Abstract][Full Text] [Related]
7. Design of High-Payload Ascorbyl Palmitate Nanosuspensions for Enhanced Skin Delivery. Park JS; Choi JH; Joung MY; Yang IG; Choi YS; Kang MJ; Ho MJ Pharmaceutics; 2024 Jan; 16(2):. PubMed ID: 38399233 [TBL] [Abstract][Full Text] [Related]
8. Rotigotine transdermal patch for the treatment of Parkinson's disease and restless legs syndrome. Boroojerdi B; Wolff HM; Braun M; Scheller DK Drugs Today (Barc); 2010 Jul; 46(7):483-505. PubMed ID: 20683503 [TBL] [Abstract][Full Text] [Related]
9. Hydroxyethyl cellulose hydrogel for skin delivery of khellin loaded in ascosomes: Characterization, in vitro/in vivo performance and acute toxicity. Risaliti L; Yu X; Vanti G; Bergonzi MC; Wang M; Bilia AR Int J Biol Macromol; 2021 May; 179():217-229. PubMed ID: 33662425 [TBL] [Abstract][Full Text] [Related]
10. A novel pH-responsive hydrogel based on carboxymethyl cellulose/2-hydroxyethyl acrylate for transdermal delivery of naringenin. Park SH; Shin HS; Park SN Carbohydr Polym; 2018 Nov; 200():341-352. PubMed ID: 30177174 [TBL] [Abstract][Full Text] [Related]
11. Dexamethasone nanocrystals-embedded hydroxypropyl methylcellulose hydrogel increases cochlear delivery and attenuates hearing loss following intratympanic injection. Jeong MY; Kim S; Kim HR; Jeon J; Won SS; Yang KJ; Park JS; Yang IG; Lee DG; Myung JH; Kim YG; Jin SG; Choi YS; Kim DK; Kang MJ Carbohydr Polym; 2024 Dec; 345():122546. PubMed ID: 39227091 [TBL] [Abstract][Full Text] [Related]
12. Rotigotine transdermal patch: a review of its use in the treatment of Parkinson's disease. Sanford M; Scott LJ CNS Drugs; 2011 Aug; 25(8):699-719. PubMed ID: 21790211 [TBL] [Abstract][Full Text] [Related]
13. Non-ergot dopamine agonist rotigotine as a promising therapeutic tool in atypical parkinsonism syndromes: a 24 months pilot observational open-label study. Moretti DV; Binetti G; Zanetti O; Frisoni GB Neuropharmacology; 2014 Oct; 85():284-9. PubMed ID: 24915072 [TBL] [Abstract][Full Text] [Related]
14. Design, optimization and characterization of atorvastatin loaded chitosan-based polyelectrolyte complex nanoparticles based transdermal patch. Patil P; Vankani A; Sawant K Int J Biol Macromol; 2024 Aug; 274(Pt 1):133219. PubMed ID: 38897514 [TBL] [Abstract][Full Text] [Related]
15. Rotigotine transdermal system for the treatment of Parkinson's disease. Pham DQ; Nogid A Clin Ther; 2008 May; 30(5):813-24. PubMed ID: 18555929 [TBL] [Abstract][Full Text] [Related]
16. Development of a hydrogel containing bisabolol-loaded nanocapsules for the treatment of atopic dermatitis in a Balb/c mice model. Karami H; Niavand MR; Haddadi R; Noriyan A; Vafaei SY Int J Pharm; 2024 May; 656():124029. PubMed ID: 38527566 [TBL] [Abstract][Full Text] [Related]
17. Self-Assembled Lecithin/Chitosan Nanoparticles Based on Phospholipid Complex: A Feasible Strategy to Improve Entrapment Efficiency and Transdermal Delivery of Poorly Lipophilic Drug. Dong W; Ye J; Wang W; Yang Y; Wang H; Sun T; Gao L; Liu Y Int J Nanomedicine; 2020; 15():5629-5643. PubMed ID: 32801706 [TBL] [Abstract][Full Text] [Related]
18. Nanosuspension-Loaded Dissolving Microneedle Patches for Enhanced Transdermal Delivery of a Highly Lipophilic Cannabidiol. Cheng A; Zhang S; Meng F; Xing M; Liu H; Yang G; Gao Y Int J Nanomedicine; 2024; 19():4061-4079. PubMed ID: 38736651 [TBL] [Abstract][Full Text] [Related]
19. Key Transdermal Patch Using Cannabidiol-Loaded Nanocarriers with Better Pharmacokinetics in vivo. Chu PC; Liao MH; Liu MG; Li CZ; Lai PS Int J Nanomedicine; 2024; 19():4321-4337. PubMed ID: 38770103 [TBL] [Abstract][Full Text] [Related]
20. A liquid crystal in situ gel based on rotigotine for the treatment of Parkinson's disease. Wu X; Cheng D; Lu Y; Rong R; Kong Y; Wang X; Niu B Drug Deliv Transl Res; 2024 Apr; 14(4):1048-1062. PubMed ID: 37875660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]